Endpoints News
Is AI jacking up healthcare costs? Read in browser
Endpoints News
Thursday, 1 October 2026
Thank you for reading, dupa dupackia!
basic
UPGRADE
THE BANK THAT TAKES YOU FROM SEED STAGE TO WORLD STAGE
J.P. Morgan was the right banking team for Montara Therapeutics. Founder Nicholas Hertz trusted the team’s life sciences expertise, security, and support to focus on what mattered most.
sponsored by J.P.Morgan
Inflationary AI
For all the talk about AI’s potential to cut healthcare costs, it seems to be doing the opposite. 
An analysis by the Blue Cross Blue Shield Association last week blamed healthcare providers’ use of AI for hiking Blues companies' claims costs by an extra $653 million over two years. The group found that hospitals are increasingly billing inpatient stays as more medically complex without actually providing more treatment.
This is an insurer-backed white paper, so we’re taking it with a grain of salt. And to be frank, the amount of additional costs isn't huge. The two-year total is just 1% of what one large Blues company paid out in benefit expenses in a single year.
Still, the idea that AI is inflating costs isn’t far-fetched. The Blues released a similar analysis in March, but the recent scrutiny over the risks of AI might be why this one’s getting more attention. 
We wrote last year that insurers were complaining in earnings calls about aggressive AI-driven coding and billing practices by hospitals. Earlier this year, Aledade CEO Farzad Mostashari warned that “bot-on-bot violence” between hospitals and insurers could jack up costs in the traditional fee-for-service healthcare environment. 
In a NEJM perspective published in July, David Blumenthal and Meredith Rosenthal of the Harvard T.H. Chan School of Public Health echoed Mostashari when they wrote that for doctors whose reimbursement is tied to volume, AI may maximize revenue by “enhancing collections for the highest justifiable level of care and capturing compensable services that previously went unbilled.”
Insurers aren’t powerless. They’ve told investors in the past that they planned to respond by using AI to restrict and deny payment. What we don’t know is just how much money they’ve saved by doing so.
But experts agree that for AI to lower costs, our health care system has to totally shift toward rewarding outcomes and cost-containment over volume. This is happening in some pockets, including in accountable care organizations and the CMS’ ACCESS model. 
But fee-for-service remains the dominant way healthcare is paid for in the US. Until that changes, expect AI to be inflationary. 
- Shelby 
P.S. - Our very own Ngai Yeung will be moderating one of the sessions at Endpoints News’ annual AI Day! She’ll be discussing the implications of AI on the healthcare workforce. Sign up to watch the virtual session here.
Here’s what’s new
Insurer startup Devoted Health raises $1.2B as it revs up growth
De­vot­ed Health, a Medicare Ad­van­tage in­sur­er and med­ical group, an­nounced near­ly $1.2 bil­lion in fresh fund­ing af­ter en­rolling hun­dreds of thou­sands of new se­nior mem­bers this year.
Exclusive: Parakeet Health raises $10M to automate patient outreach
A start­up that au­to­mates pa­tient com­mu­ni­ca­tions just raised $10 mil­lion, End­points News learned ex­clu­sive­ly.
Rise in complex coding
A chart shows the change in complex claims codes from 2023 to 2025.

According to a chart from the Blue Cross Blue Shield Association's hospital coding analysis, the share of cases billed as complex rose from 37.5% in early 2023 to 39.8% in late 2025. Hospitals increasingly added secondary diagnoses that pushed claims into higher severity, more costly diagnosis-related groups, without an increase in clinical care, the group found.

This week in health Тech
OpenAI unveiled its new AI agents, dots, at its annual DevDay conference on Tuesday. The announcement follows the launch of Meta's Muse agent, which can help people book healthcare appointments and call insurance, among a range of other administrative and daily tasks.
EliseAI raised $350 million to automate healthcare and housing operations. The round, led by Andreessen Horowitz, values the company at $4 billion. Andreessen Horowitz previously led the company’s Series E round in August 2025. 
Relevant for Health Tech readers: Former UnitedHealth Group CEO Andrew Witty is now chairman of Hatteras Venture Partners, our colleague Kyle LaHucik reports. Witty had previously been a venture partner at the firm, which invests across biotech, medtech and health tech. 
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter linkedin
Worldwide made. Thanks for reading.
Unsubscribe preferences
Unsubscribe from all newsletters
FT Specialist Logo A service from the Financial Times